2025. Novel Sustained-Release Nateglinide Microspheres: In Vitro Evaluation for Improved Antidiabetic Therapy. Journal of Carcinogenesis. 24, 6s (Sep. 2025), 232–242. DOI:https://doi.org/10.64149/J.Carcinog.24.6s.232-242.